Lower Patient Anxiety and Unchanged Levels of Adherence to Hemato-Oncologic Treatment in Response to New Measures to Reduce Hospital Exposure Risk to COVID-19.
Nadav SaridShir MannYair HerishanuChava PerryYael C CohenInna PassageMiriam NeamanNoam BenyaminiMaayan JeanIrit AviviPublished in: Patient preference and adherence (2021)
Reorganization of the hemato-oncology unit and provision of information to patients reduced COVID-19-related anxiety and enabled the same delivery of therapy as that prior to the pandemic.
Keyphrases
- coronavirus disease
- sars cov
- end stage renal disease
- palliative care
- chronic kidney disease
- newly diagnosed
- ejection fraction
- respiratory syndrome coronavirus
- emergency department
- peritoneal dialysis
- prostate cancer
- rectal cancer
- type diabetes
- stem cells
- patient reported outcomes
- mesenchymal stem cells
- physical activity
- skeletal muscle
- adverse drug
- bone marrow
- health information
- robot assisted